Boniva Injection (Ibandronate Sodium) - Summary

SUMMARY

BONIVA^®
(ibandronate sodium)
INJECTION

BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption.

BONIVA Injection is indicated for the treatment of osteoporosis in postmenopausal women.

In postmenopausal women with osteoporosis, BONIVA increases BMD and reduces the incidence of vertebral fractures (see CLINICAL PHARMACOLOGY: Clinical Studies). Osteoporosis may be confirmed by the presence or history of osteoporotic fracture or by a finding of low bone mass (BMD more than 2.0 standard deviations below the premenopausal mean [ie, T-score]).

NEWS HIGHLIGHTS RELATED TO BONIVA INJECTION

Media Articles Related to Boniva Injection (Ibandronic Acid)

NPS Pharma says Glaxo stops osteoporosis drug study (Reuters)
Source: Y! Health Osteoporosis News [2008.09.25]

Long-Term Osteoporosis Risk in Men Rises with Weight Loss
Source: MedPage Today Endocrinology [2008.09.19]

ACP Issues Treatment Guideline for Osteoporosis
Source: MedPage Today Endocrinology [2008.09.17]

New Merck osteoporosis drug boosts bone density (AP)
Source: Y! Health Osteoporosis News [2008.09.16]

Most Women With Osteoporosis Unaware of Raised Fracture Risk
Source: MedicineNet Fracture Specialty [2008.09.16]

more>>

Published Studies Related to Boniva Injection (Ibandronic Acid)

Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial. [2006]

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). [2005.12]

Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease. [2008.05.27]

Eletriptan: a review of its use in the acute treatment of migraine. [2006]

Oral ibandronic acid. [2005.02]

more>>

Clinical Trials Related to Boniva Injection (Ibandronic Acid)

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. [Active, not recruiting]

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva [Completed]

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis [Active, not recruiting]

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. [Active, not recruiting]

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. [Active, not recruiting]

more>>